I highly doubt this will spread (as any sort of trend), as it is clearly-specific as a financial challenge -- to this company's Roundup litigation woes. But we will keep an eye on it, just the same:
. . .Bayer AG is planning to slash its dividend by 95% in an effort to pay down debt as the German company looks to recover from multiple crises including a wave of litigation over Roundup herbicide.
Bayer will present a plan to offer investors 11 euro cents ($0.12) per share for fiscal year 2023, down from €2.40 last year, according to a statement Monday. . . .
Now you know. But pharmas have always been dividend kings. Likely to decline in the coming days -- by about 20% -- so, maybe not so much of a king, any longer.
नमस्ते
No comments:
Post a Comment